Myasthenia gravis trials in South Korea

5 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

  Where

  Busan, Daegu, Seoul

  Age

  18 years and over

  People

  199 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT04951622 · EU 2023-504152-97-00
• Phase 2/3Taking people
  A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

  Where

  Seoul

  Age

  12 years to 17 years

  People

  8 worldwide

  Run by

  UCB Biopharma SRL

  See details and how to joinNCT06055959 · EU 2022-502072-23-00
• Phase 3Taking people
  Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  Where

  Daegu, Gwangju, Seoul

  Age

  18 years and over

  People

  264 worldwide

  Run by

  Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

  See details and how to joinNCT06463587 · EU 2023-507746-83-00
• Phase 3Enrolling by invitation
  An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

  Where

  Seoul

  Age

  12 years to 17 years

  People

  8 worldwide

  Run by

  UCB Biopharma SRL

  See details and how to joinNCT06435312 · EU 2022-502073-42-00
• No phaseTaking people
  Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

  Where

  Seoul

  People

  75 worldwide

  Run by

  Alexion Pharmaceuticals, Inc.

  See details and how to joinNCT06312644